Oncotarget: Glucocorticoid receptor antagonism promotes apoptosis in solid tumor cells

(Impact Journals LLC) Support recently reported findings of clinical benefit when relacorilant is added to paclitaxel-containing therapy in patients with ovarian and pancreatic cancers and provide a new rationale for combining relacorilant with additional cytotoxic agents.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news